Assignee
PROYECTO BIOMEDICINA CIMA SL
ES·10 granted patents·14 pending applications·38 citations·filing 1999–2015
Top patents by PatentIndex Score
24 records- 0177US7829077B2Treatment of hepatitis C with compositions comprising oncostatin M and interferon alphaPROYECTO BIOMEDICINA CIMA SL·Filed 2006·Granted Nov 9, 2010·8 cites·22 claims
- 0268US7528226B2TGFβ1-inhibitor peptidesPROYECTO BIOMEDICINA CIMA SL·Filed 2006·Granted May 5, 2009·1 cites·13 claims
- 0365US7057013B1TGFβ1 inhibitor peptidesPROYECTO BIOMEDICINA CIMA SL·Filed 1999·Granted Jun 6, 2006·25 cites·11 claims
- 0460US7820637B2Use of 5′-methylthioadenosine (MTA) in the prevention and/or treatment of autoimmune diseases and/or transplant rejectionPROYECTO BIOMEDICINA CIMA SL·Filed 2005·Granted Oct 26, 2010·2 cites·7 claims
- 0556US7666841B2Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1)PROYECTO BIOMEDICINA CIMA SL·Filed 2004·Granted Feb 23, 2010·1 cites·10 claims
- 0653US2011081718A1System for packaging high-capacity adenovirusesPROYECTO BIOMEDICINA CIMA SL·Filed 2009·Application pending·0 cites
- 0752US2007264637A111q DELETION AS A MOLECULAR GENETIC MARKER IN BREAST CANCERPROYECTO BIOMEDICINA CIMA SL·Filed 2006·Application pending·0 cites
- 0850US2011030075A1Methods and Compositions Capable of Causing Post-Transcriptional Silencing of Gene Expression in a Synergic MannerPROYECTO BIOMEDICINA CIMA SL·Filed 2009·Application pending·0 cites
- 0947US7501392B2Method of treatment of viral hepatitis C with interferon alpha 5PROYECTO BIOMEDICINA CIMA SL·Filed 2005·Granted Mar 10, 2009·0 cites·8 claims
- 1046US8012973B2Compounds for the treatment of auricular fibrillationPROYECTO BIOMEDICINA CIMA SL·Filed 2006·Granted Sep 6, 2011·0 cites·8 claims
- 1146US2009263410A1Use of tgf-b1 inhibitor peptides in the preparation of an immune response modulating agentPROYECTO BIOMEDICINA CIMA SL·Filed 2005·Application pending·0 cites
- 1245US2014056943A1Immuno-stimulant combination for prophylaxis and treatment of hepatitis cPROYECTO BIOMEDICINA CIMA SL·Filed 2013·Application pending·0 cites
- 1342US2011195047A1Oncostatin m as promoter of immunostimulatory activity of human epithelial cellsPROYECTO BIOMEDICINA CIMA SL·Filed 2009·Application pending·0 cites
- 1442US2011070623A1Self-inactivating helper adenoviruses for the production of high-capactiy recombinant adenovirusesPROYECTO BIOMEDICINA CIMA SL·Filed 2009·Application pending·0 cites
- 1541US7732397B2Use of cardiotrophin in liver diseasesPROYECTO BIOMEDICINA CIMA SL·Filed 2004·Granted Jun 8, 2010·0 cites·16 claims
- 1640US2013273006A1Methods and compositions for the treatment of cirrhosis and liver fibrosisPROYECTO BIOMEDICINA CIMA SL·Filed 2013·Application pending·0 cites
- 1737US2010055736A1Viral vector and uses thereofPROYECTO BIOMEDICINA CIMA SL·Filed 2007·Application pending·0 cites
- 1836US2009181379A1Molecular markers of hepatocellular carcinoma and their applicationsPROYECTO BIOMEDICINA CIMA SL·Filed 2006·Application pending·0 cites
- 1936US2009117591A1Fibrosis MarkersPROYECTO BIOMEDICINA CIMA SL·Filed 2006·Application pending·0 cites
- 2036US2011076304A1Adapter molecule for the delivery of adenovirus vectorsPROYECTO BIOMEDICINA CIMA SL·Filed 2009·Application pending·0 cites
- 2135US2011027251A1Novel uses for 4-phenylbutyrate (4pba) and its pharmaceutically acceptable saltsPROYECTO BIOMEDICINA CIMA SL·Filed 2009·Application pending·0 cites
- 2235US2016074475A1Conjugates for the administration of biologically active compoundsPROYECTO BIOMEDICINA CIMA SL·Filed 2015·Application pending·0 cites
- 2331US7850957B2Adenovirus/alphavirus hybrid vector for the effective administration and expression of therapeutic genes in tumour cellsPROYECTO BIOMEDICINA CIMA SL·Filed 2005·Granted Dec 14, 2010·0 cites·29 claims
- 2427US6995133B1Utilization of interferon alpha 5 in the treatment of viral hepatopathiesPROYECTO BIOMEDICINA CIMA SL·Filed 1999·Granted Feb 7, 2006·1 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when PROYECTO BIOMEDICINA CIMA SL files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →